May 4, 2021

Featuring perspectives from Dr Mark D Pegram on the following topics:

• Case presentations and San Antonio Breast Cancer Symposium (SABCS®) review of locally advanced and high-risk HER2-positive breast cancer
• • Introduction (0:00)
  • Case: A 49-year-old woman who received neoadjuvant TCHP, currently awaiting surgery — Estelamari Rodriguez, MD, MPH (5:12)
  • Case: A 55-year-old woman with Stage I HER2-positive breast cancer — Kelly Yap, MD (23:46)
  • Case: A 45-year-old woman who received postoperative T-DM1 after neoadjuvant TCHP — Philip Glynn, MD (26:30)
  • Case: A 39-year-old woman with localized disease and a positive cervical node on PET scan — Dr Rodriguez (32:00)
• Case presentations and SABCS review of metastatic HER2-positive breast cancer
• • Case: A 70-year-old woman with a 10-cm Grade III, ER/PR-negative, HER2-positive infiltrating ductal carcinoma and pleural metastases — Alan B Astrow, MD (38:24)
  • Case: An 87-year-old woman with pretreated HER2-positive metastatic breast cancer now with negative (low) HER2 — Yanjun Ma, MD (43:25)
  • Case: A 60-year-old woman with malignant pericardial effusion — Dr Glynn (50:23)
  • Case: A 43-year-old woman who develops brain metastases after prior TCHP — Dr Yap (53:09)

CME information and select publications